Use of nonprescription weight loss products: Results from a multistate survey

JAMA

Volumn 286, Issue 8, 2001, Pages 930-935

  Blanck, Heidi Michels ^a,b   Khan, Laura Kettel ^a   Serdula, Mary K ^a  

^a NATIONAL CENTER FOR CHRONIC DISEASE PREVENTION AND HEALTH PROMOTION   (United States)

^b CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CHROMIUM PICOLINATE; NON PRESCRIPTION DRUG; PHENYLPROPANOLAMINE;

ADULT; ARTICLE; CONTROLLED STUDY; DIABETES MELLITUS; DIET SUPPLEMENTATION; DRUG USE; EPHEDRA; FEMALE; FRUIT; HEALTH SURVEY; HUMAN; HYPERICUM PERFORATUM; LIFESTYLE; MAJOR CLINICAL STUDY; MALE; OBESITY; PHYSICAL ACTIVITY; PRIORITY JOURNAL; RISK FACTOR; UNITED STATES; VEGETABLE; WEIGHT REDUCTION;

EID: 0035934053     PISSN: 00987484     EISSN: None     Source Type: Journal    
DOI: 10.1001/jama.286.8.930     Document Type: Article

References (27)

1. Nonvitamin, nonmineral dietary supplements: Issues and findings from NHANES III
2. The effect and safety of an ephedrine/caffeine compound compared to ephedrine, caffeine, and placebo in obese subjects on an energy restricted diet: A double blind trial
3. Thermogenic synergism between ephedrine and caffeine in healthy volunteers: A double-blind, placebo-controlled study
4. Alternative treatments for weight loss: A critical review
5. Dietary supplements containing ephedrine alkaloids
6. Dietary supplements containing ephedrine alkaloids; withdrawal in part
7. Phenylpropanolamine hydrochloride
8. Double-blind, randomized, placebo-controlled clinical trials with non-prescription medications for the treatment of obesity
9. Toxicity of over-the-counter stimulants
10. Adverse drug effects attributed to phenylpropanolamine: A review of 142 case reports
11. Nonprescription drugs and hypertension: Which ones affect blood pressure
12. Phenylpropanolamine and the risk of hemorrhagic stroke
13. Objectives and design of the Behavioral Risk Factor Surveillance System
14. Weight control practices of US adults trying to lose weight
15. Adverse cardiovascular and central nervous system events associated with dietary supplements containing ephedra alkaloids
16. Regulatory environment for dietary supplements and botanicals targeted to weight loss
17. Content versus label claims in ephedra-containing dietary supplements
18. Trends in alternative medicine use in the United States, 1990-1997
19. Beta-adrenergic receptors in pathophysiologic states and in clinical medicine
20. Keeping up with the increasing popularity of nonvitamin, nonmineral supplements
21. The spread of the obesity epidemic in the United States 1991-1998